Inventor · disambiguated record
Jun O. Liu
Also filed as: LIU JUN · LIU JUN O
36 granted patents·32 pending applications·393 citations·filing 1997–2024
97Inventor score
Files withUNIV JOHNS HOPKINS29NOVARTIS AG8LIU JUN O6MASSACHUSETTS INST TECHNOLOGY4OLALEYE OMONIKE ARIKE4
Top patents by PatentIndex Score
68 records- 0194US6566541B2Type 2 methionine aminopeptidase (MetAP2) inhibitors and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted May 20, 2003·77 cites·4 claims
- 0293US9250237B2Hybrid cyclic libraries and screens thereofLIU JUN O·Filed 2011·Granted Feb 2, 2016·39 cites·28 claims
- 0392US6207704B1Type 2 methionine aminopeptidase [MetAP2] inhibitors and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted Mar 27, 2001·81 cites·8 claims
- 0491US9346791B2Itraconazole analogs and use thereofLIU JUN O·Filed 2012·Granted May 24, 2016·17 cites·15 claims
- 0589US11555054B2Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereofUNIV JOHNS HOPKINS·Filed 2020·Granted Jan 17, 2023·2 cites·3 claims
- 0689US10774110B2Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereofUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 15, 2020·5 cites·4 claims
- 0786US9783577B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 10, 2017·5 cites·11 claims
- 0886US8729097B2Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disordersLIU JUN O·Filed 2009·Granted May 20, 2014·19 cites·22 claims
- 0984US9095589B2Chirally pure isomers of itraconazole for use as angiogenesis inhibitorsLIU JUN O·Filed 2012·Granted Aug 4, 2015·5 cites·9 claims
- 1083US11708391B2Rapaglutins, novel inhibitors of GLUT and use thereofUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 25, 2023·3 cites·4 claims
- 1183US10414801B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 17, 2019·3 cites·11 claims
- 1283US8653083B2Hedgehog pathway antagonists to treat diseaseBEACHY PHILIP A·Filed 2006·Granted Feb 18, 2014·6 cites·17 claims
- 1382US11028078B2Itraconazole analogs and use thereofUNIV JOHNS HOPKINS·Filed 2018·Granted Jun 8, 2021·3 cites·2 claims
- 1481US8980930B2Angiogenesis inhibitorsLIU JUN·Filed 2005·Granted Mar 17, 2015·4 cites·10 claims
- 1581US7737134B2Anticancer agents and useTEXAS A & M UNIV SYS·Filed 2006·Granted Jun 15, 2010·4 cites·27 claims
- 1680US5928868AThree hybrid screening assayMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted Jul 27, 1999·88 cites·33 claims
- 1779US8841285B2Potent immunosuppressive agents, derivatives and usesROMO DANIEL·Filed 2010·Granted Sep 23, 2014·4 cites·10 claims
- 1877US11458141B2Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Oct 4, 2022·1 cites·9 claims
- 1976US12049521B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2021·Granted Jul 30, 2024·0 cites·10 claims
- 2076US10954273B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·0 cites·8 claims
- 2175US7230021B2Potent, simplified derivatives of pateamine ATEXAS A & M UNIV SYS·Filed 2003·Granted Jun 12, 2007·11 cites·13 claims
- 2272US10662220B2Synthesis and composition of rapafucin librariesUNIV JOHNS HOPKINS·Filed 2017·Granted May 26, 2020·2 cites·5 claims
- 2370US8669257B2Phenazine derivatives and uses thereof as potassium channel modulatorsLIU JUN O·Filed 2010·Granted Mar 11, 2014·5 cites·8 claims
- 2470US2024350606A1Vaccine compositions and methods for enhanced antigen-specific vaccinationUNIV DUKE·Filed 2024·Application pending·0 cites
- 2565US10695319B2Glucose conjugates of triptolide, analogs and uses thereofUNIV JOHNS HOPKINS·Filed 2017·Granted Jun 30, 2020·1 cites·33 claims
- 2665US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2764US12459910B2Mitochondrial therapeutic agentsUNIV ARIZONA STATE·Filed 2021·Granted Nov 4, 2025·0 cites·20 claims
- 2863US9642865B2Angiogenesis inhibitorsUNIV JOHNS HOPKINS·Filed 2014·Granted May 9, 2017·0 cites·19 claims
- 2961US2025283138A1Bioreactive compounds and methods of use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3061US2024360111A1Itraconazole analogs and use thereofUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 3159US11878045B2Inducing cell death by hyperactivation of motility networksUNIV JOHNS HOPKINS·Filed 2020·Granted Jan 23, 2024·0 cites·17 claims
- 3258US2017202985A1Imaging and therapy of virus-associated tumorsUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 3357US2015141415A1Methionine Aminopeptidase Inhibitors for Treating Infectious DiseasesOLALEYE OMONIKE ARIKE·Filed 2014·Application pending·0 cites
- 3454US2011176998A1Imaging and therapy of virus-associated tumorsUNIV JOHNS HOPKINS·Filed 2010·Application pending·0 cites
- 3554US2023134986A1Glucose triptolide conjugates and uses thereofUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3654US2019203301A1Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation statusNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3753US2021154208A1Method to Identify Agents That Can Overcome Inhibition Caused By Drug-protein Binding of the Human Plasma Protein, Alpha-1-acid GlycoproteinUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 3852US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 3952US2021106667A1Vaccine compositions and methods for enhanced antigen-specific vaccinationUNIV DUKE·Filed 2019·Application pending·0 cites
- 4052US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 4152US2013101657A1Angiogenesis inhibitorsUNIV JOHNS HOPKINS·Filed 2012·Application pending·0 cites
- 4251US12493045B2Multi-target crosslinkers and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Dec 9, 2025·0 cites·30 claims
- 4351US2020297693A1Glucose conjugates of triptolide, analogs and uses thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4451US2015125857A1CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUSNOVARTIS AG·Filed 2013·Application pending·0 cites
- 4550US10869908B2Inducing cell death by hyperactivation of motility networksUNIV JOHNS HOPKINS·Filed 2017·Granted Dec 22, 2020·0 cites·21 claims
- 4650US2017071948A1Methionine Aminopeptidase Inhibitors for Treating Infectious DiseasesOLALEYE OMONIKE ARIKE·Filed 2016·Application pending·0 cites
- 4750US2016264556A1Itraconazole analogs and use thereofUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 4850US2017071940A1Methionine Aminopeptidase Inhibitors for Treating Infectious DiseasesOLALEYE OMONIKE ARIKE·Filed 2016·Application pending·0 cites
- 4949US2011124649A1Inhibitors of human methionine aminopeptidase 1 and methods of treating disordersUNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 5049US2017071951A1Methionine Aminopeptidase Inhibitors for Treating Infectious DiseasesOLALEYE OMONIKE ARIKE·Filed 2016·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jun O. Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →